medullary thyroid cancer semaglutide survivor wondering about GLP-1 medications? , Here’s what you need to know! 👆, Most thyroid cancers (papillary & follicular) = ✅ SAFE , thyroid carcinoma = ❌ AVOID, Always medullary thyroid cancer and semaglutide

After 6 months of treatment, your doctor will assess your progress to see if you have lost at least 5% of your starting body weight

However, this percentage can vary based on factors such as diet, exercise, and individual response to the medication

Researchers matched participants using statistical techniques to account for differences in age, health conditions, and other factors that might skew results

Our ranges of protein shakes, fibre drinks and sleep blends are all designed to boost your nutrition and support a healthy weight loss journey

Abu-Huwaij R, Zidan AN

1 Should retatrutide affect energy expenditure in humans, it could not only help to explain weight reduction but also might influence retatrutide's effects on appetiterelated constructs